Ifp Advisors, Inc X Biotech Inc. Transaction History

Ifp Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$5.13 - $9.2 $1,026 - $1,839	200 New	200 $1,000
Q2 2022 Aug 12, 2022	SELL	$5.13 - $9.2 $1,026 - $1,839	-200 Closed	0 $0
Q1 2022 Sep 06, 2022	SELL	$8.64 - $11.71 $4,320 - $5,855	-500 Reduced 71.43%	200 $1,000
Q3 2020 Oct 29, 2020	BUY	$13.97 - $21.16 $1,397 - $2,116	100 Added 16.67%	700 $14,000
Q2 2020 Aug 05, 2020	BUY	$10.39 - $16.07 $6,234 - $9,642	600 New	600 $8,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $203M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.